Pentobra: A potent antibiotic with multiple layers of selective antimicrobial mechanisms against propionibacterium acnes

Journal of Investigative Dermatology

Volumn 135, Issue 6, 2015, Pages 1581-1589

  Schmidt, Nathan W ^a,b   Agak, George W ^c   Deshayes, Stephanie ^a,b   Yu, Yang ^c   Blacker, Alyssa ^a,b   Champer, Jackson ^c   Xian, Wujing ^a,b   Kasko, Andrea M ^b   Kim, Jenny ^b,c,d   Wong, Gerard C L ^a,b  

^a Engineering IV   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CHEMOKINE; PENTOBRA; TOBRAMYCIN; UNCLASSIFIED DRUG; CYTOKINE; PEPTIDE;

ACNE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL STRUCTURE; CELL SURFACE; COMEDO; CONTROLLED STUDY; DRUG POTENCY; HUMAN CELL CULTURE; IN VITRO STUDY; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RIBOSOME; SEBACEOUS GLAND; ACNE VULGARIS; ANTIBIOTIC RESISTANCE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MONOCYTE; SKIN; SPECIES DIFFERENCE; STEM CELL;

ACNE VULGARIS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CYTOKINES; DRUG RESISTANCE, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MONOCYTES; PEPTIDES; PROPIONIBACTERIUM ACNES; SKIN; SPECIES SPECIFICITY; STEM CELLS; TOBRAMYCIN;

EID: 84960095604     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.40     Document Type: Article

References (52)

1. Agak GW, Qin M, Nobe J et al. (2014) Propionibacterium acnes induces an IL-17 response in Acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol 134:366-73
2. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-20
3. Bals R, Wang X, Wu Z et al. (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874
4. Bowdish D, Davidson D, Hancock R (2006) Immunomodulatory properties of defensins and cathelicidins. In: Antimicrobial Peptides and Human Disease. Springer, Berlin, Heidelberg, 27-66
5. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-50
6. Bryan L, Kowand S, Van Den Elzen H (1979) Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother 15:7-13
7. Cooper AJ (1998) Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 169:259-61
8. Davis BD (1987) Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51:341
9. Davis BD, Chen LL, Tai PC (1986) Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci 83:6164-8
10. Derossi D, Joliot AH, Chassaing G et al. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269:10444-50
11. Dréno B, Bettoli V, Ochsendorf F et al. (2004) European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 14:391-9
12. Dürr UH, Sudheendra U, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758:1408-25
13. Eady E, Gloor M, Leyden J (2003) Propionibacterium acnes resistance: a worldwide problem. Dermatology 206:54-6
14. Fischbach MA (2011) Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol 14:519-23
15. Fitz-Gibbon S, Tomida S, Chiu B-H et al. (2013) Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 133:2152-60
16. Fourmy D, Recht MI, Blanchard SC et al. (1996) Structure of the Ä site of Escherichia coli 16 S ribosomal RNA complexée! with an aminoglycoside antibiotic. Science 274:1367-71
17. Guo L, Lim KB, Gunn JS et al. (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-3
18. Hancock RE, Sahl H-G (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-7
19. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
20. Harder J, Bartels J, Christophers E et al. (1997) A peptide antibiotic from human skin. Nature 387:861
21. Hu K, Schmidt NW, Zhu R et al. (2013) A critical evaluation of random copolymer mimesis of homogeneous antimicrobial peptides. Macromole-cules 46:1908-15
22. Humphrey S (2012) Antibiotic resistance in acne treatment. Skin Ther Lett 17: 1-3
23. Hurdle JG, O'Neill AJ, Chopra I et al. (2011) Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9:62-75
24. Joliot A, Pernelle C, Deagostini-Bazin H et al. (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci 88:1864-8
25. Kim J, Ochoa M-T, Krutzik SR et al. (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-41
26. Koprivnjak T, Peschel A (2011) Bacterial resistance mechanisms against host defense peptides. Cell Mol Life Sci 68:2243-54
27. Li M, Lai Y, Villaruz AE et al. (2007) Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci 104:9469-74
28. Magnet S, Blanchard JS (2004) Molecular insights into aminoglycoside action and resistance. Chem Rev 105:477-98
29. McDowell A, Nagy I, Magyari M et al. (2013) The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution. PLoS One 8:e70897
30. McInturff JE, Wang S-J, Machleidt T et al. (2005) Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propioni-bacterium acnes. J Invest Dermatol 125:256-63
31. Mishra A, Lai GH, Schmidt NW et al. (2011) Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Proc Natl Acad Sci 108:16883-8
32. Piérard-Franchimont C, Goffin V, Arrese JE et al. (2002) Lymecycline and minocycline in inflammatory acne. Skin Pharmacol Physiol 15:112-9
33. Qin M, Pirouz A, Kim MH et al. (2014) Propionibacterium acnes induces IL-1beta secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol 134:381-8
34. Rosenfeld Y, Shai Y (2006) Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758:1513-22
35. Ross J, Snelling A, Carnegie E et al. (2003) Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 148:467-78
36. Schmidt NW, Deshayes S, Hawker S et al. (2014) Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano 8: 8786-93
37. Schmidt NW, Lis M, Zhao K et al. (2012a) Molecular basis for nanoscopic membrane curvature generation from quantum mechanical models and synthetic transporter sequences. J Am Chem Soc 134:19207-16
38. Schmidt NW, Mishra A, Lai GH et al. (2011) Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc 133:6720-7
39. Schmidt NW, Tai KP, Kamdar K et al. (2012b) Arginine in α-defensins: differental effects on bactericidal activity correspond to geometry of membrane curvature and peptide-lipid phase behavior. J Biol Chem 287: 21866-72
40. Schmidt NW, Wong GC (2013) Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering. Curr Opin Solid State Mater Sci 17:151-63
41. Scott MG, Davidson DJ, Gold MR et al. (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 169:3883-91
42. Scott MG, Vreugdenhil AC, Buurman WA et al. (2000) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164:549-53
43. Taber HW, Mueller J, Miller P et al. (1987) Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51:439
44. Vicens Q, Westhof E (2002) Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site. Chem Biol 9:747-55
45. Vowels B, Yang S, Leyden J (1995a) Pro-inflammatory cytokines are inducible by a soluble factor of Propionibacterium acnes: evidence of peptidoglycan involvement. J Invest Dermatol 104:683 ABSTRACT
46. Vowels BR, Yang S, Leyden JJ (1995b) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158-65
47. Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775-81
48. Wang WLL, Everett ED, Johnson M et al. (1977) Susceptibility of Propioni-bacterium acnes to seventeen antibiotics. Antimicrob Agents Chemother 11:171-3
49. Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379: 361-72
50. Worthington RJ, Melander C (2013) Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 31:177-84
51. Yang L, Gordon VD, Trinkle DR et al. (2008) Mechanism of a prototypical synthetic membrane-active antimicrobial: efficient hole-punching via interaction with negative intrinsic curvature lipids. Proc Natl Acad Sci 105: 20595-600
52. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-95